Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Genitourinary 4Head & Neck 3Gastrointestinal 3Other 2Lymphoid 2Plasma cell 1Other hematologic neoplasm 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 3102Precursor Cell Lymphoblastic Leukemia-Lymphoma 2086Leukemia 2013Leukemia, Lymphocytic, Chronic, B-Cell 1771Myelodysplastic Syndromes 1298Hematologic Neoplasms 1067Lymphoma 1029Lymphoma, Non-Hodgkin 981Leukemia, Myelogenous, Chronic, BCR-ABL Positive 713Lymphoma, Follicular 704Lymphoma, Mantle-Cell 678Lymphoma, Large B-Cell, Diffuse 657Burkitt Lymphoma 642Multiple Myeloma 639Lymphoma, B-Cell, Marginal Zone 599Recurrence 587Hodgkin Disease 575Leukemia, Myelomonocytic, Chronic 495Lymphoma, Large-Cell, Immunoblastic 419Neoplasms 402Myeloproliferative Disorders 402Leukemia, Myeloid, Chronic-Phase 391Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 382Congenital Abnormalities 357Waldenstrom Macroglobulinemia 330Blast Crisis 324Leukemia, Myeloid, Accelerated Phase 290Lymphoma, T-Cell, Cutaneous 280Primary Myelofibrosis 270Anemia, Refractory, with Excess of Blasts 251

Interventions

Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Arthritis × Other hematologic neoplasm × Clear all
NCT00017680 2008-06-09

Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis

Office of Rare Diseases (ORD)

Phase 2 Completed
25 enrolled
Other hematologic neoplasmPlasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis, Arthritis, Connective Tissue Diseases, Hematologic Neoplasms, Genetic Diseases, Inborn, Rare Diseases, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡